ArticleInternational journal of medical sciences2026
High-Glucose Environment Promotes Radioresistance in Colorectal Cancer via SERPINE1-Enhanced DNA Repair and Anti-Apoptosis.
Article in International journal of medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patients with colorectal cancer (CRC) and comorbid hyperglycemia often exhibit poor responses to preoperative concurrent chemoradiotherapy (CCRT), leading to unfavorable clinical outcomes. However, how hyperglycemia contributes to CRC radioresistance remains incompletely understood. This study aimed to elucidate the molecular mechanisms by which high-glucose exposure promotes radioresistance in CRC. Methods: CRC cell lines (SW480 and HCT116) were cultured under normal-glucose (5 mM), high-glucose (25 mM), or mannitol osmotic control conditions to assess malignant behaviors and radiosensitivity. Relative miRNA expression changes from pooled plasma exosomal miRNA profiling were integrated with TargetScan, miRDB, GeneCards, and TCGA analyses to screen for candidate mediators. Candidate SERPINE1-regulating miRNAs were validated using mimic/inhibitor assays. The functional role of SERPINE1 was validated using siRNA knockdown and plasmid overexpression assays, followed by assays of clonogenic survival, apoptosis, γ-H2AX foci kinetics, and DNA repair-associated protein expression. Results: High-glucose culture significantly enhanced CRC cell proliferation, migration, invasion, epithelial-mesenchymal transition, cancer stemness, and clonogenic radioresistance, whereas mannitol did not reproduce these effects. Integrated exploratory exosomal miRNA and bioinformatic analyses identified SERPINE1 as a candidate mediator associated with hyperglycemia, radioresistance, and poor prognosis. Selected hyperglycemia-associated miRNAs functionally modulated SERPINE1 protein expression in CRC cells. We confirmed that high glucose upregulates SERPINE1 expression Conclusion: High-glucose exposure promotes CRC malignancy and radioresistance, at least in part, through SERPINE1 upregulation. SERPINE1 contributes to radioresistance by attenuating apoptosis and facilitating radiation-induced DNA damage resolution. These findings support SERPINE1 as a key mechanistic mediator linking high-glucose exposure to radioresistance in CRC cell models. Because the exosomal miRNA profiling was performed using pooled plasma samples, the resulting miRNA findings should be regarded as exploratory and do not constitute a validated biomarker signature. The potential clinical relevance of SERPINE1 requires further validation in independent patient cohorts and physiologically relevant
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.